Payment overview · 2025
General Payments
$1,935.23
60 reported records · 17 companies
Healthcare provider profile · identity verified
Michael Todd Peacock, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · EASTMAN, GA · NPI 1487636742
Verified facts
What the public records show
CMS Open Payments records show Michael Todd Peacock, M.D. received $1,935.23 in general payments during 2025 across 60 reported records.
Neurocrine BioSciences, Inc. accounted for 35.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 17 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Austedo Xr, Briviact, Gemtesa, Ingrezza, Jardiance, Lokelma, Mounjaro, Rexulti.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AIRSUPRA as an associated drug or biological on 165148 records involving 56069 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Airsupra by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 117 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 219 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LOKELMA as an associated drug or biological on 6897 records involving 4326 distinct recipient NPIs. Public Medicare Part D data also shows 28 claims for Lokelma by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 51 claims for Symbicort by this doctor in 2024.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 1050 claims for Jardiance by this doctor in 2024.
E.R. Squibb & Sons, L.L.C. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 27956 records involving 14870 distinct recipient NPIs. Public Medicare Part D data also shows 2814 claims for Eliquis by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 1050 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 61 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 166 claims for Trulicity by this doctor in 2024.
Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 71829 records involving 25812 distinct recipient NPIs. Public Medicare Part D data also shows 116 claims for Rexulti by this doctor in 2024.
Neurocrine BioSciences, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported INGREZZA as an associated drug or biological on 126456 records involving 27390 distinct recipient NPIs. Public Medicare Part D data also shows 20 claims for Ingrezza by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Fiasp as an associated drug or biological on 15 records involving 15 distinct recipient NPIs. Public Medicare Part D data also shows 98 claims for Fiasp by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 98 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 20 claims for Rybelsus by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 58 claims for Nuedexta by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 116 claims for Rexulti by this doctor in 2024.
Otsuka Pharmaceutical Development & Commercialization, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 1463 records involving 1088 distinct recipient NPIs. Public Medicare Part D data also shows 116 claims for Rexulti by this doctor in 2024.
Sumitomo Pharma America, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported APTIOM as an associated drug or biological on 11 records involving 11 distinct recipient NPIs. Public Medicare Part D data also shows 316 claims for Aptiom by this doctor in 2024.
Sumitomo Pharma America, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported GEMTESA as an associated drug or biological on 61692 records involving 22152 distinct recipient NPIs. Public Medicare Part D data also shows 1078 claims for Gemtesa by this doctor in 2024.
Teva Pharmaceuticals USA, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AUSTEDO as an associated drug or biological on 28 records involving 15 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Austedo by this doctor in 2024.
Teva Pharmaceuticals USA, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AUSTEDO XR as an associated drug or biological on 86263 records involving 23643 distinct recipient NPIs. Public Medicare Part D data also shows 32 claims for Austedo Xr by this doctor in 2024.
UCB, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Briviact as an associated drug or biological on 13595 records involving 4444 distinct recipient NPIs. Public Medicare Part D data also shows 619 claims for Briviact by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $692.19 | 35.8% | 19 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $489.31 | 25.3% | 15 | 2025 |
| SK Life Science, Inc. |
SK Life Science, Inc. exact · evidence 2025-04-03 |
$156.50 | 8.1% | 2 | 2025 |
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $104.00 | 5.4% | 2 | 2025 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | Unresolved — no canonical attribution shown | $103.01 | 5.3% | 1 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $93.37 | 4.8% | 5 | 2025 |
| UCB, Inc. | Unresolved — no canonical attribution shown | $70.44 | 3.6% | 3 | 2025 |
| Esperion Therapeutics, Inc. | Unresolved — no canonical attribution shown | $29.50 | 1.5% | 2 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $27.62 | 1.4% | 2 | 2025 |
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $24.18 | 1.2% | 1 | 2025 |
| Alpha Cognition USA, Inc. | Unresolved — no canonical attribution shown | $23.16 | 1.2% | 2 | 2025 |
| E.R. Squibb & Sons, L.L.C. | Unresolved — no canonical attribution shown | $22.18 | 1.1% | 1 | 2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $20.65 | 1.1% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $20.25 | 1.1% | 1 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $20.10 | 1.0% | 1 | 2025 |
| Vanda Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $19.68 | 1.0% | 1 | 2025 |
| Sumitomo Pharma America, Inc. | Unresolved — no canonical attribution shown | $19.09 | 1.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $1,853.74 | 59 |
| Education | $81.49 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC, Otsuka America Pharmaceutical, Inc., Otsuka Pharmaceutical Development & Commercialization, Inc. | $685.69 | 21 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $574.18 | 18 | 2025 |
Source payment records
|
|||||
| Briviact Normalized: briviact |
Drug | UCB, Inc. | $37.06 | 1 | 2025 |
Source payment records
|
|||||
| Nayzilam Normalized: nayzilam |
Drug | UCB, Inc. | $33.38 | 2 | 2025 |
Source payment records
|
|||||
| NEXLETOL Normalized: nexletol |
Drug | Esperion Therapeutics, Inc. | $29.50 | 2 | 2025 |
Source payment records
|
|||||
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $24.18 | 1 | 2025 |
Source payment records
|
|||||
| Zunveyl Normalized: zunveyl |
Drug | Alpha Cognition USA, Inc. | $23.16 | 2 | 2025 |
Source payment records
|
|||||
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $22.51 | 1 | 2025 |
Source payment records
|
|||||
| COBENFY Normalized: cobenfy |
Drug | E.R. Squibb & Sons, L.L.C. | $22.18 | 1 | 2025 |
Source payment records
|
|||||
| JARDIANCE Normalized: jardiance |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $20.65 | 1 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $20.25 | 1 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $20.10 | 1 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $20.10 | 1 | 2025 |
Source payment records
|
|||||
| FANAPT Normalized: fanapt |
Drug | Vanda Pharmaceuticals Inc. | $19.68 | 1 | 2025 |
Source payment records
|
|||||
| GEMTESA Normalized: gemtesa |
Drug | Sumitomo Pharma America, Inc. | $19.09 | 1 | 2025 |
Source payment records
|
|||||
| BREZTRI Normalized: breztri |
Drug | AstraZeneca Pharmaceuticals LP | $14.02 | 1 | 2025 |
Source payment records
|
|||||
| LOKELMA Normalized: lokelma |
Drug | AstraZeneca Pharmaceuticals LP | $13.60 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| AUSTEDO XR austedo xr |
2025 | Austedo Xr | 2024 | 32 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| Briviact briviact |
2025 | Briviact | 2024 | 619 | exact normalized | Medicare Part D |
| GEMTESA gemtesa |
2025 | Gemtesa | 2024 | 1078 | exact normalized | Medicare Part D |
| INGREZZA ingrezza |
2025 | Ingrezza | 2024 | 20 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 1050 | exact normalized | Medicare Part D |
| LOKELMA lokelma |
2025 | Lokelma | 2024 | 28 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| MOUNJARO mounjaro |
2025 | Mounjaro | 2024 | 61 | exact normalized | Medicare Part D |
| REXULTI rexulti |
2025 | Rexulti | 2024 | 116 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | AIRSUPRA open payments reported associated product |
CMS Open Payments — General Payments 165148 supporting records · 56069 recipient NPIs · example record 1206131344 |
Airsupra · 2024 Exact normalized brand match · 1 Part D row |
18 | 12 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
117 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
219 | 22 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | LOKELMA open payments reported associated product |
CMS Open Payments — General Payments 6897 supporting records · 4326 recipient NPIs · example record 1206131624 |
Lokelma · 2024 Exact normalized brand match · 1 Part D row |
28 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
51 | 15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
1050 | 91 |
| E.R. Squibb & Sons, L.L.C. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 27956 supporting records · 14870 recipient NPIs · example record 1184377713 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
2814 | 253 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
1050 | 91 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
61 | 16 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
166 | 24 |
| Lundbeck LLC Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 71829 supporting records · 25812 recipient NPIs · example record 1251759986 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
116 | 12 |
| Neurocrine BioSciences, Inc. Exact reporting entity; no affiliate inference |
2025 | INGREZZA open payments reported associated product |
CMS Open Payments — General Payments 126456 supporting records · 27390 recipient NPIs · example record 1242766729 |
Ingrezza · 2024 Exact normalized brand match · 1 Part D row |
20 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Fiasp open payments reported associated product |
CMS Open Payments — General Payments 15 supporting records · 15 recipient NPIs · example record 1188262936 |
Fiasp · 2024 Exact normalized brand match · 1 Part D row |
98 | 36 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
98 | 22 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
20 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | NUEDEXTA open payments reported associated product |
CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901 |
Nuedexta · 2024 Exact normalized brand match · 1 Part D row |
58 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
116 | 12 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 1463 supporting records · 1088 recipient NPIs · example record 1225319865 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
116 | 12 |
| Sumitomo Pharma America, Inc. Exact reporting entity; no affiliate inference |
2025 | APTIOM open payments reported associated product |
CMS Open Payments — General Payments 11 supporting records · 11 recipient NPIs · example record 1176658319 |
Aptiom · 2024 Exact normalized brand match · 1 Part D row |
316 | 18 |
| Sumitomo Pharma America, Inc. Exact reporting entity; no affiliate inference |
2025 | GEMTESA open payments reported associated product |
CMS Open Payments — General Payments 61692 supporting records · 22152 recipient NPIs · example record 1176593503 |
Gemtesa · 2024 Exact normalized brand match · 1 Part D row |
1078 | 72 |
| Teva Pharmaceuticals USA, Inc. Exact reporting entity; no affiliate inference |
2025 | AUSTEDO open payments reported associated product |
CMS Open Payments — General Payments 28 supporting records · 15 recipient NPIs · example record 1247249192 |
Austedo · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
| Teva Pharmaceuticals USA, Inc. Exact reporting entity; no affiliate inference |
2025 | AUSTEDO XR open payments reported associated product |
CMS Open Payments — General Payments 86263 supporting records · 23643 recipient NPIs · example record 1247244228 |
Austedo Xr · 2024 Exact normalized brand match · 1 Part D row |
32 | suppressed by CMS |
| UCB, Inc. Exact reporting entity; no affiliate inference |
2025 | Briviact open payments reported associated product |
CMS Open Payments — General Payments 13595 supporting records · 4444 recipient NPIs · example record 1224348489 |
Briviact · 2024 Exact normalized brand match · 1 Part D row |
619 | 65 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 4786 | 598 |
| Amlodipine Besylate | Amlodipine Besylate | 3764 | 427 |
| Gabapentin | Gabapentin | 3687 | 421 |
| Levothyroxine Sodium | Levothyroxine Sodium | 3049 | 297 |
| Furosemide | Furosemide | 3007 | 359 |
| Eliquis | Apixaban | 2814 | 253 |
| Potassium Chloride | Potassium Chloride | 2771 | 341 |
| Trazodone Hcl | Trazodone Hcl | 2612 | 324 |
| Pantoprazole Sodium | Pantoprazole Sodium | 2438 | 330 |
| Mirtazapine | Mirtazapine | 2303 | 302 |
| Divalproex Sodium | Divalproex Sodium | 2291 | 288 |
| Famotidine | Famotidine | 2025 | 180 |
| Losartan Potassium | Losartan Potassium | 1990 | 241 |
| Clopidogrel | Clopidogrel Bisulfate | 1939 | 210 |
| Quetiapine Fumarate | Quetiapine Fumarate | 1917 | 229 |
| Carvedilol | Carvedilol | 1912 | 230 |
| Sertraline Hcl | Sertraline Hcl | 1879 | 201 |
| Lisinopril | Lisinopril | 1716 | 204 |
| Donepezil Hcl | Donepezil Hcl | 1686 | 182 |
| Metoprolol Tartrate | Metoprolol Tartrate | 1684 | 218 |
| Metformin Hcl | Metformin Hcl | 1672 | 198 |
| Tamsulosin Hcl | Tamsulosin Hcl | 1659 | 213 |
| Omeprazole | Omeprazole | 1626 | 224 |
| Buspirone Hcl | Buspirone Hcl | 1457 | 166 |
| Memantine Hcl | Memantine Hcl | 1445 | 137 |
| Olanzapine | Olanzapine | 1401 | 164 |
| Metoprolol Succinate | Metoprolol Succinate | 1347 | 151 |
| Escitalopram Oxalate | Escitalopram Oxalate | 1338 | 160 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 1257 | 214 |
| Citalopram Hbr | Citalopram Hydrobromide | 1176 | 105 |
| Levetiracetam | Levetiracetam | 1154 | 166 |
| Hydralazine Hcl | Hydralazine Hcl | 1083 | 117 |
| Gemtesa | Vibegron | 1078 | 72 |
| Jardiance | Empagliflozin | 1050 | 91 |
| Risperidone | Risperidone | 989 | 135 |
| Tramadol Hcl | Tramadol Hcl | 827 | 193 |
| Meloxicam | Meloxicam | 799 | 117 |
| Duloxetine Hcl | Duloxetine Hcl | 723 | 83 |
| Fluoxetine Hcl | Fluoxetine Hcl | 703 | 66 |
| Lorazepam | Lorazepam | 694 | 135 |
| Oxcarbazepine | Oxcarbazepine | 693 | 64 |
| Hydrochlorothiazide | Hydrochlorothiazide | 644 | 94 |
| Montelukast Sodium | Montelukast Sodium | 635 | 68 |
| Briviact | Brivaracetam | 619 | 65 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 613 | 77 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 608 | 62 |
| Simvastatin | Simvastatin | 605 | 73 |
| Aripiprazole | Aripiprazole | 591 | 64 |
| Pravastatin Sodium | Pravastatin Sodium | 589 | 70 |
| Midodrine Hcl | Midodrine Hcl | 573 | 72 |
| Nifedipine Er | Nifedipine | 571 | 52 |
| Allopurinol | Allopurinol | 556 | 66 |
| Doxazosin Mesylate | Doxazosin Mesylate | 547 | 52 |
| Benztropine Mesylate | Benztropine Mesylate | 533 | 68 |
| Xarelto | Rivaroxaban | 529 | 36 |
| Tizanidine Hcl | Tizanidine Hcl | 520 | 95 |
| Ondansetron Hcl | Ondansetron Hcl | 517 | 214 |
| Clonazepam | Clonazepam | 501 | 78 |
| Enulose | Lactulose | 486 | 47 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 480 | 41 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 469 | 69 |
| Sucralfate | Sucralfate | 465 | 49 |
| Ropinirole Hcl | Ropinirole Hcl | 458 | 64 |
| Ezetimibe | Ezetimibe | 437 | 57 |
| Oxycodone Hcl | Oxycodone Hcl | 421 | 67 |
| Torsemide | Torsemide | 414 | 83 |
| Latanoprost | Latanoprost | 411 | 94 |
| Spironolactone | Spironolactone | 410 | 76 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 402 | 169 |
| Baclofen | Baclofen | 400 | 52 |
| Haloperidol | Haloperidol | 390 | 69 |
| Pioglitazone Hcl | Pioglitazone Hcl | 379 | 49 |
| Lamotrigine | Lamotrigine | 378 | 41 |
| Prednisone | Prednisone | 369 | 79 |
| Paroxetine Hcl | Paroxetine Hcl | 365 | 43 |
| Myrbetriq | Mirabegron | 363 | 28 |
| Fluticasone Propionate | Fluticasone Propionate | 362 | 126 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 352 | 58 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 346 | 38 |
| Januvia | Sitagliptin Phosphate | 342 | 32 |
| Propranolol Hcl | Propranolol Hcl | 341 | 41 |
| Linzess | Linaclotide | 330 | 80 |
| Finasteride | Finasteride | 326 | 53 |
| Amiodarone Hcl | Amiodarone Hcl | 322 | 63 |
| Entresto | Sacubitril/Valsartan | 319 | 26 |
| Aptiom | Eslicarbazepine Acetate | 316 | 18 |
| Alendronate Sodium | Alendronate Sodium | 311 | 26 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 287 | 40 |
| Topiramate | Topiramate | 285 | 41 |
| Clonidine Hcl | Clonidine Hcl | 284 | 63 |
| Lactulose | Lactulose | 280 | 44 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 271 | 42 |
| Bupropion Xl | Bupropion Hcl | 270 | 41 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 267 | 160 |
| Pregabalin | Pregabalin | 267 | 52 |
| Bumetanide | Bumetanide | 258 | 29 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 250 | 63 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 242 | 59 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 239 | 26 |
| Divalproex Sodium Er | Divalproex Sodium | 238 | 30 |
| Valsartan | Valsartan | 238 | 33 |
| Alprazolam | Alprazolam | 237 | 56 |
| Haloperidol Lactate | Haloperidol Lactate | 233 | 116 |
| Ranolazine Er | Ranolazine | 230 | 19 |
| Farxiga | Dapagliflozin Propanediol | 219 | 22 |
| Ziprasidone Hcl | Ziprasidone Hcl | 217 | 32 |
| Lithium Carbonate | Lithium Carbonate | 211 | 19 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 206 | 34 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 205 | 81 |
| Lacosamide | Lacosamide | 203 | 28 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 200 | 72 |
| Atenolol | Atenolol | 198 | 23 |
| Haloperidol Decanoate | Haloperidol Decanoate | 197 | 30 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 192 | 31 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 192 | 28 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 190 | 68 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 188 | 72 |
| Ibuprofen | Ibuprofen | 187 | 57 |
| Fenofibrate | Fenofibrate Nanocrystallized | 182 | 24 |
| Metoclopramide Hcl | Metoclopramide Hcl | 181 | 26 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 175 | 113 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 174 | 120 |
| Cilostazol | Cilostazol | 172 | 11 |
| Megestrol Acetate | Megestrol Acetate | 172 | 38 |
| Diclofenac Sodium | Diclofenac Sodium | 171 | 66 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 166 | 45 |
| Sevelamer Carbonate | Sevelamer Carbonate | 166 | 27 |
| Trulicity | Dulaglutide | 166 | 24 |
| Ceftriaxone | Ceftriaxone Sodium | 164 | 108 |
| Glipizide | Glipizide | 157 | 29 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 156 | 60 |
| Digoxin | Digoxin | 155 | 25 |
| Perphenazine | Perphenazine | 155 | suppressed |
| Calcium Acetate | Calcium Acetate | 154 | 17 |
| Fentanyl | Fentanyl | 154 | 21 |
| Insulin Aspart Flexpen | Insulin Aspart | 151 | 55 |
| Tradjenta | Linagliptin | 150 | 12 |
| Azithromycin | Azithromycin | 149 | 120 |
| Ketoconazole | Ketoconazole | 149 | 56 |
| Novolog | Insulin Aspart | 149 | 51 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 147 | 37 |
| Metolazone | Metolazone | 146 | 22 |
| Bupropion Hcl Sr | Bupropion Hcl | 145 | 18 |
| Primidone | Primidone | 144 | 20 |
| Doxycycline Hyclate | Doxycycline Hyclate | 140 | 79 |
| Amantadine | Amantadine Hcl | 137 | 16 |
| Novolog Flexpen | Insulin Aspart | 137 | 43 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 132 | 24 |
| Meclizine Hcl | Meclizine Hcl | 130 | 28 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 129 | 13 |
| Clozapine | Clozapine | 128 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 128 | 15 |
| Cephalexin | Cephalexin | 125 | 74 |
| Promethazine Hcl | Promethazine Hcl | 124 | 48 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 122 | suppressed |
| Fenofibrate | Fenofibrate | 122 | 18 |
| Memantine Hcl Er | Memantine Hcl | 120 | 14 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 120 | 28 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 118 | 36 |
| Brilinta | Ticagrelor | 117 | suppressed |
| Rexulti | Brexpiprazole | 116 | 12 |
| Levofloxacin | Levofloxacin | 113 | 82 |
| Nystatin | Nystatin | 111 | 62 |
| Warfarin Sodium | Warfarin Sodium | 111 | 11 |
| Fluconazole | Fluconazole | 107 | 69 |
| Vraylar | Cariprazine Hcl | 107 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 106 | 18 |
| Glimepiride | Glimepiride | 105 | 22 |
| Carbamazepine | Carbamazepine | 104 | 13 |
| Breo Ellipta | Fluticasone/Vilanterol | 102 | 25 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 100 | 68 |
| Albuterol Sulfate | Albuterol Sulfate | 99 | 45 |
| Tresiba Flextouch U-100 | Insulin Degludec | 99 | 22 |
| Fiasp | Insulin Aspart (Niacinamide) | 98 | 36 |
| Ozempic | Semaglutide | 98 | 22 |
| Scopolamine | Scopolamine | 98 | 20 |
| Clindamycin Hcl | Clindamycin Hcl | 97 | 61 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 96 | 33 |
| Oxybutynin Chloride | Oxybutynin Chloride | 96 | 19 |
| Humalog | Insulin Lispro | 95 | 40 |
| Levemir Flexpen | Insulin Detemir | 92 | 29 |
| Dicyclomine Hcl | Dicyclomine Hcl | 90 | 24 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 89 | 17 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 88 | 26 |
| Bupropion Hcl | Bupropion Hcl | 87 | 15 |
| Namzaric | Memantine Hcl/Donepezil Hcl | 86 | suppressed |
| Levemir | Insulin Detemir | 84 | 34 |
| Calcitriol | Calcitriol | 82 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 81 | 21 |
| Mupirocin | Mupirocin | 80 | 52 |
| Insulin Lispro | Insulin Lispro | 78 | 38 |
| Nitroglycerin | Nitroglycerin | 77 | 53 |
| Prazosin Hcl | Prazosin Hcl | 77 | suppressed |
| Rivastigmine | Rivastigmine | 77 | 14 |
| Clonidine | Clonidine | 76 | 16 |
| Colchicine | Colchicine | 76 | 14 |
| Doxepin Hcl | Doxepin Hcl | 75 | 14 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 74 | 15 |
| Lidocaine Hcl | Lidocaine Hcl | 74 | 59 |
| Novolin R | Insulin Regular, Human | 74 | 17 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 74 | suppressed |
| Amoxicillin | Amoxicillin | 73 | 52 |
| Lubiprostone | Lubiprostone | 72 | 14 |
| Morphine Sulfate Er | Morphine Sulfate | 72 | 15 |
| Valacyclovir | Valacyclovir Hcl | 71 | 16 |
| Ondansetron Odt | Ondansetron | 70 | 31 |
| Nebivolol Hcl | Nebivolol Hcl | 69 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 69 | 17 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 68 | suppressed |
| Methocarbamol | Methocarbamol | 68 | 20 |
| Nortriptyline Hcl | Nortriptyline Hcl | 68 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 67 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 65 | suppressed |
| Carbamazepine Er | Carbamazepine | 65 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 65 | 21 |
| Risperidone Er | Risperidone Microspheres | 65 | 20 |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 64 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 62 | 11 |
| Cinacalcet Hcl | Cinacalcet Hcl | 61 | suppressed |
| Mounjaro | Tirzepatide | 61 | 16 |
| Nystop | Nystatin | 61 | 40 |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 60 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 60 | suppressed |
| Methimazole | Methimazole | 60 | suppressed |
| Phenobarbital | Phenobarbital | 60 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 59 | 14 |
| Insulin Aspart | Insulin Aspart | 59 | 33 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 58 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 58 | 14 |
| Telmisartan | Telmisartan | 58 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 57 | suppressed |
| Diphenhydramine Hcl | Diphenhydramine Hcl | 57 | 23 |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 57 | 26 |
| Olanzapine Odt | Olanzapine | 56 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 53 | suppressed |
| Temazepam | Temazepam | 53 | 19 |
| Tivicay | Dolutegravir Sodium | 53 | suppressed |
| Celecoxib | Celecoxib | 52 | 15 |
| Labetalol Hcl | Labetalol Hcl | 52 | suppressed |
| Methylprednisolone | Methylprednisolone | 52 | 45 |
| Restasis | Cyclosporine | 52 | suppressed |
| Xifaxan | Rifaximin | 52 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 51 | 26 |
| Symbicort | Budesonide/Formoterol Fumarate | 51 | 15 |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 50 | 38 |
| Brimonidine Tartrate | Brimonidine Tartrate | 49 | 13 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 49 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 48 | 25 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 48 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 48 | suppressed |
| Timolol Maleate | Timolol Maleate | 48 | 12 |
| Chlorthalidone | Chlorthalidone | 47 | 11 |
| Prednisolone Acetate | Prednisolone Acetate | 47 | 18 |
| Bromocriptine Mesylate | Bromocriptine Mesylate | 46 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 46 | 20 |
| Metronidazole | Metronidazole | 46 | 28 |
| Naltrexone Hcl | Naltrexone Hcl | 46 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 45 | suppressed |
| Gvoke Pfs 1-Pack Syringe | Glucagon | 45 | 16 |
| Morphine Sulfate | Morphine Sulfate | 45 | 18 |
| Tolterodine Tartrate | Tolterodine Tartrate | 45 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 44 | suppressed |
| Zonisamide | Zonisamide | 43 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 42 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 41 | suppressed |
| Gvoke Hypopen 2-Pack | Glucagon | 41 | suppressed |
| Insulin Degludec Pen (U-100) | Insulin Degludec | 41 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 41 | 13 |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 40 | suppressed |
| Semglee (Yfgn) | Insulin Glargine-Yfgn | 40 | 14 |
| Solifenacin Succinate | Solifenacin Succinate | 40 | suppressed |
| Belsomra | Suvorexant | 39 | suppressed |
| Humulin R | Insulin Regular, Human | 39 | suppressed |
| Acetazolamide | Acetazolamide | 38 | suppressed |
| Cefdinir | Cefdinir | 38 | 23 |
| Tobramycin | Tobramycin | 38 | 36 |
| Incruse Ellipta | Umeclidinium Bromide | 37 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 37 | suppressed |
| Admelog | Insulin Lispro | 36 | suppressed |
| Lovastatin | Lovastatin | 36 | suppressed |
| Verapamil Er | Verapamil Hcl | 36 | suppressed |
| Dexamethasone | Dexamethasone | 35 | 16 |
| Novolin R Flexpen | Insulin Regular, Human | 35 | 12 |
| Zolpidem Tartrate | Zolpidem Tartrate | 35 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 34 | suppressed |
| Dexamethasone Sodium Phosphate | Dexamethasone Sodium Phosphate | 33 | 25 |
| Enalapril Maleate | Enalapril Maleate | 33 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 33 | suppressed |
| Lumigan | Bimatoprost | 33 | suppressed |
| Roflumilast | Roflumilast | 33 | suppressed |
| Sotalol | Sotalol Hcl | 33 | suppressed |
| Austedo Xr | Deutetrabenazine | 32 | suppressed |
| Cyclosporine | Cyclosporine | 32 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 32 | 11 |
| Lurasidone Hcl | Lurasidone Hcl | 32 | suppressed |
| Methotrexate | Methotrexate Sodium | 32 | suppressed |
| Erythromycin | Erythromycin Base | 31 | 28 |
| Pentoxifylline | Pentoxifylline | 31 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 31 | suppressed |
| Budesonide | Budesonide | 30 | suppressed |
| Buprenorphine | Buprenorphine | 29 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 29 | suppressed |
| Estradiol | Estradiol | 29 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 28 | 16 |
| Breyna | Budesonide/Formoterol Fumarate | 28 | 12 |
| Cimetidine | Cimetidine | 28 | suppressed |
| Ertapenem | Ertapenem Sodium | 28 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 28 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 28 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 28 | 13 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 27 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 27 | 14 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 27 | suppressed |
| Novolog Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 27 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 27 | suppressed |
| Dutasteride | Dutasteride | 26 | suppressed |
| Hydroxyurea | Hydroxyurea | 26 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 26 | 11 |
| Sevelamer Hcl | Sevelamer Hcl | 26 | suppressed |
| Simbrinza | Brinzolamide/Brimonidine Tart | 26 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 26 | 19 |
| Ziprasidone Mesylate | Ziprasidone Mesylate | 26 | 19 |
| Dorzolamide Hcl | Dorzolamide Hcl | 25 | suppressed |
| Fluphenazine Decanoate | Fluphenazine Decanoate | 25 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 25 | suppressed |
| Letrozole | Letrozole | 25 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 25 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 24 | suppressed |
| Glipizide Er | Glipizide | 24 | suppressed |
| Anastrozole | Anastrozole | 23 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 23 | suppressed |
| Etravirine | Etravirine | 23 | suppressed |
| Glucagon Emergency Kit | Glucagon | 23 | 16 |
| Lansoprazole | Lansoprazole | 23 | suppressed |
| Phenytoin | Phenytoin | 23 | suppressed |
| Unifine Safecontrol Pen Needle | Pen Needle,dual Safety,diabetc | 23 | 14 |
| Atovaquone | Atovaquone | 22 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 22 | suppressed |
| Lidocaine | Lidocaine | 22 | 12 |
| Prezcobix | Darunavir/Cobicistat | 22 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 22 | suppressed |
| Symtuza | Darunavir/Cob/Emtri/Tenof Alaf | 22 | suppressed |
| Vascepa | Icosapent Ethyl | 22 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 21 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 21 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 21 | suppressed |
| Hydrocortisone | Hydrocortisone | 21 | 13 |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 21 | suppressed |
| Febuxostat | Febuxostat | 20 | suppressed |
| Folic Acid | Folic Acid | 20 | suppressed |
| Ingrezza | Valbenazine Tosylate | 20 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 20 | suppressed |
| Mesalamine Dr | Mesalamine | 20 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 20 | suppressed |
| Rybelsus | Semaglutide | 20 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 20 | 11 |
| Brinzolamide | Brinzolamide | 19 | suppressed |
| Descovy | Emtricitabine/Tenofov Alafenam | 19 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 19 | 17 |
| Nyamyc | Nystatin | 19 | 13 |
| Airsupra | Albuterol Sulfate/Budesonide | 18 | 12 |
| Daptomycin | Daptomycin | 18 | suppressed |
| Fycompa | Perampanel | 18 | suppressed |
| Movantik | Naloxegol Oxalate | 18 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 18 | 13 |
| Austedo | Deutetrabenazine | 17 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 17 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 17 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 17 | suppressed |
| Tegretol Xr | Carbamazepine | 17 | suppressed |
| Diazepam | Diazepam | 16 | suppressed |
| Galantamine Er | Galantamine Hbr | 16 | suppressed |
| Gemfibrozil | Gemfibrozil | 16 | suppressed |
| Genvoya | Elviteg/Cob/Emtri/Tenof Alafen | 16 | suppressed |
| Minoxidil | Minoxidil | 16 | suppressed |
| Naproxen | Naproxen | 16 | suppressed |
| Paliperidone Er | Paliperidone | 16 | suppressed |
| Risperidone Odt | Risperidone | 16 | suppressed |
| Teflaro | Ceftaroline Fosamil Acetate | 16 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 16 | suppressed |
| Trospium Chloride | Trospium Chloride | 16 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 16 | 11 |
| Abacavir | Abacavir Sulfate | 15 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 15 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 15 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 15 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 15 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 15 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Verapamil Er Pm | Verapamil Hcl | 15 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 14 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 14 | suppressed |
| Clotrimazole | Clotrimazole | 14 | 11 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 14 | suppressed |
| Norethindrone | Norethindrone | 14 | suppressed |
| Ritonavir | Ritonavir | 14 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 14 | suppressed |
| Thiothixene | Thiothixene | 14 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 13 | 11 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 13 | 11 |
| Insulin Aspart Prot Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 13 | suppressed |
| Kesimpta Pen | Ofatumumab | 13 | suppressed |
| Klor-Con | Potassium Chloride | 13 | suppressed |
| Lamivudine | Lamivudine | 13 | suppressed |
| Levalbuterol Hcl | Levalbuterol Hcl | 13 | suppressed |
| Renvela | Sevelamer Carbonate | 13 | suppressed |
| Ssd | Silver Sulfadiazine | 13 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 13 | suppressed |
| Acyclovir | Acyclovir | 12 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 12 | suppressed |
| Clomipramine Hcl | Clomipramine Hcl | 12 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 12 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 12 | suppressed |
| Efavirenz-Emtric-Tenofov Disop | Efavirenz/Emtricit/Tenofovr Df | 12 | suppressed |
| Enalapril-Hydrochlorothiazide | Enalapril/Hydrochlorothiazide | 12 | suppressed |
| Etodolac | Etodolac | 12 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 12 | suppressed |
| Glucagen | Glucagon | 12 | suppressed |
| Humulin N Kwikpen | Insulin Nph Human Isophane | 12 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 12 | suppressed |
| Lamotrigine Er | Lamotrigine | 12 | suppressed |
| Lithium Carbonate Er | Lithium Carbonate | 12 | suppressed |
| Loperamide | Loperamide Hcl | 12 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 12 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Paxlovid (Eua) | Nirmatrelvir/Ritonavir | 12 | 12 |
| Rayaldee | Calcifediol | 12 | suppressed |
| Teriflunomide | Teriflunomide | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Zosyn | Piperacillin-Tazo-Dextrose,iso | 12 | suppressed |
| Aliskiren | Aliskiren Hemifumarate | 11 | suppressed |
| Dapsone | Dapsone | 11 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 11 | suppressed |
| Leflunomide | Leflunomide | 11 | suppressed |
| Lybalvi | Olanzapine/Samidorphan Malate | 11 | suppressed |
| Moxifloxacin | Moxifloxacin Hcl | 11 | suppressed |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 11 | 11 |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 11 | suppressed |
| Repatha Sureclick | Evolocumab | 11 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 11 | suppressed |
| Ulticare Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $1,935.23 · 60 records | Neurocrine BioSciences, Inc. | AUSTEDO XR, BREZTRI, Briviact, COBENFY, FANAPT, GEMTESA, INGREZZA, JARDIANCE, Kerendia, LOKELMA, MOUNJARO, NEXLETOL, Nayzilam, REXULTI, Wegovy, ZEPBOUND, Zunveyl | 23 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Austedo Xr play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error